ArticleClinical cancer research : an official journal of the American Association for Cancer Research2013

Phase I study of panobinostat plus everolimus in patients with relapsed or refractory lymphoma.

Yasuhiro Oki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.